Versor Investments LP Increases Stake in Maximus, Inc. (NYSE:MMS)

Versor Investments LP raised its holdings in shares of Maximus, Inc. (NYSE:MMS) by 213.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,500 shares of the health services provider’s stock after purchasing an additional 5,789 shares during the quarter. Versor Investments LP’s holdings in Maximus were worth $792,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of Maximus by 2.4% in the first quarter. Vanguard Group Inc. now owns 6,208,839 shares of the health services provider’s stock valued at $520,922,000 after purchasing an additional 145,983 shares in the last quarter. Janus Henderson Group PLC increased its holdings in shares of Maximus by 2.1% in the 1st quarter. Janus Henderson Group PLC now owns 1,254,536 shares of the health services provider’s stock worth $105,255,000 after buying an additional 25,825 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Maximus by 7.4% during the second quarter. Dimensional Fund Advisors LP now owns 1,153,977 shares of the health services provider’s stock worth $98,904,000 after purchasing an additional 79,092 shares during the last quarter. Van Berkom & Associates Inc. grew its holdings in shares of Maximus by 0.8% during the 2nd quarter. Van Berkom & Associates Inc. now owns 1,146,524 shares of the health services provider’s stock valued at $98,257,000 after purchasing an additional 8,811 shares during the last quarter. Finally, Assenagon Asset Management S.A. increased its stake in Maximus by 277.0% in the 3rd quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider’s stock worth $81,878,000 after purchasing an additional 645,760 shares during the period. Institutional investors own 97.21% of the company’s stock.

Maximus Stock Performance

Shares of MMS stock opened at $90.55 on Wednesday. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.61. Maximus, Inc. has a 52 week low of $75.29 and a 52 week high of $93.97. The stock has a fifty day moving average of $89.38 and a 200 day moving average of $88.18. The firm has a market capitalization of $5.45 billion, a price-to-earnings ratio of 18.98 and a beta of 0.77.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Saturday, November 30th. Stockholders of record on Friday, November 15th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.33%. The ex-dividend date of this dividend is Friday, November 15th. Maximus’s dividend payout ratio is currently 25.16%.

Insider Buying and Selling at Maximus

In other Maximus news, insider Michelle F. Link sold 1,363 shares of the company’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the sale, the insider now directly owns 6,567 shares of the company’s stock, valued at approximately $607,841.52. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.40% of the company’s stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.